NM_020944.3:c.2220C>A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_020944.3(GBA2):​c.2220C>A​(p.Ser740Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00081 in 1,613,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00084 ( 0 hom. )

Consequence

GBA2
NM_020944.3 missense

Scores

5
6
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 6.75

Publications

4 publications found
Variant links:
Genes affected
GBA2 (HGNC:18986): (glucosylceramidase beta 2) This gene encodes a microsomal beta-glucosidase that catalyzes the hydrolysis of bile acid 3-O-glucosides as endogenous compounds. Studies to determine subcellular localization of this protein in the liver indicated that the enzyme was mainly enriched in the microsomal fraction where it appeared to be confined to the endoplasmic reticulum. This putative transmembrane protein is thought to play a role in carbohydrate transport and metabolism. [provided by RefSeq, Jul 2008]
CREB3 (HGNC:2347): (cAMP responsive element binding protein 3) This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. This protein binds to the cAMP-response element and regulates cell proliferation. The protein interacts with host cell factor C1, which also associates with the herpes simplex virus (HSV) protein VP16 that induces transcription of HSV immediate-early genes. This protein and VP16 both bind to the same site on host cell factor C1. It is thought that the interaction between this protein and host cell factor C1 plays a role in the establishment of latency during HSV infection. This protein also plays a role in leukocyte migration, tumor suppression, and endoplasmic reticulum stress-associated protein degradation. Additional transcript variants have been identified, but their biological validity has not been determined.[provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14968792).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000512 (78/152334) while in subpopulation SAS AF = 0.00104 (5/4828). AF 95% confidence interval is 0.000625. There are 0 homozygotes in GnomAd4. There are 44 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020944.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA2
NM_020944.3
MANE Select
c.2220C>Ap.Ser740Arg
missense
Exon 15 of 17NP_065995.1Q9HCG7-1
GBA2
NM_001330660.2
c.2220C>Ap.Ser740Arg
missense
Exon 15 of 17NP_001317589.1Q9HCG7-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA2
ENST00000378103.7
TSL:1 MANE Select
c.2220C>Ap.Ser740Arg
missense
Exon 15 of 17ENSP00000367343.3Q9HCG7-1
GBA2
ENST00000378094.4
TSL:1
c.2220C>Ap.Ser740Arg
missense
Exon 15 of 17ENSP00000367334.4Q9HCG7-2
GBA2
ENST00000467252.5
TSL:1
n.1792C>A
non_coding_transcript_exon
Exon 12 of 13

Frequencies

GnomAD3 genomes
AF:
0.000512
AC:
78
AN:
152216
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000794
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000469
AC:
118
AN:
251376
AF XY:
0.000442
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000774
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000841
AC:
1229
AN:
1461630
Hom.:
0
Cov.:
32
AF XY:
0.000846
AC XY:
615
AN XY:
727128
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33472
American (AMR)
AF:
0.000134
AC:
6
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000522
AC:
45
AN:
86256
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53416
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00101
AC:
1125
AN:
1111784
Other (OTH)
AF:
0.000745
AC:
45
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
69
138
208
277
346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000512
AC:
78
AN:
152334
Hom.:
0
Cov.:
32
AF XY:
0.000591
AC XY:
44
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41572
American (AMR)
AF:
0.000653
AC:
10
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000794
AC:
54
AN:
68032
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000574
Hom.:
0
Bravo
AF:
0.000642
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000478
AC:
58
EpiCase
AF:
0.000818
EpiControl
AF:
0.000533

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
1
-
Hereditary spastic paraplegia (1)
-
1
-
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.15
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.87
D
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
D
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.15
T
MetaSVM
Uncertain
0.040
D
MutationAssessor
Uncertain
2.9
M
PhyloP100
6.7
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-3.1
D
REVEL
Uncertain
0.64
Sift
Benign
0.36
T
Sift4G
Benign
0.34
T
Polyphen
0.97
D
Vest4
0.50
MVP
0.86
MPC
0.83
ClinPred
0.11
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.51
gMVP
0.73
Mutation Taster
=53/47
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200894732; hg19: chr9-35738127; API